The DOI matches its Crossref record; 166 of the 166 references it cites were found in a registry or an index.
The JAK-STAT pathway at 30: Much learned, much more to do
Open accessAbstract
The discovery of the Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway arose from investigations of how cells respond to interferons (IFNs), revealing a paradigm in cell signaling conserved from slime molds to mammals. These discoveries revealed mechanisms underlying rapid gene expression mediated by a wide variety of extracellular polypeptides including cytokines, interleukins and related factors. This knowledge has provided numerous insights into human disease, from immune deficiencies to cancer, and was rapidly translated to new drugs for autoimmune, allergic, and infectious disease, including Covid-19. Despite these advances, major challenges and opportunities remain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biomolecular condensates: organizers of cellular biochemistry
Banani, S. F., Lee, H. O., Hyman, A. A., & Rosen, M. K. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.7 · Cited by 6,100
COSMIC: the Catalogue Of Somatic Mutations In Cancer
Tate, J. G., Bamford, S., Jubb, H. C., Sondka, Z., Beare, D. M., Bindal, N., Boutselakis, H., Cole, C. G., Creatore, C., Dawson, E., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1015 · Cited by 4,867
Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes
Whyte, W. A., Orlando, D. A., Hnisz, D., Abraham, B. J., Lin, C. Y., Kagey, M. H., Rahl, P. B., Lee, T. I., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.03.035 · Cited by 4,143
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
Kralovics, R., Passamonti, F., Buser, A. S., Teo, S.-S., Tiedt, R., Passweg, J. R., Tichelli, A., Cazzola, M., & Skoda, R. C. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051113 · Cited by 3,470
Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
Zaretsky, J. M., Garcia-Diaz, A., Shin, D. S., Escuin-Ordinas, H., Hugo, W., Hu-Lieskovan, S., Torrejon, D. Y., Abril-Rodriguez, G., Sandoval, S., Barthly, L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1604958 · Cited by 3,237
Liquid-Liquid Phase Separation in Biology
Hyman, A. A., Weber, C. A., & Jülicher, F. (2014) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100913-013325 · Cited by 3,155
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790
Self-citationZhong, Z., Wen, Z., & Darnell, J. E. (1994) · Science · doi:10.1126/science.8140422 · Cited by 2,070
A Phase Separation Model for Transcriptional Control
Hnisz, D., Shrinivas, K., Young, R. A., Chakraborty, A. K., & Sharp, P. A. (2017) · Cell · doi:10.1016/j.cell.2017.02.007 · Cited by 1,753
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
Zhang, J., Ding, L., Holmfeldt, L., Wu, G., Heatley, S. L., Payne-Turner, D., Easton, J., Chen, X., Wang, J., Rusch, M., et al. (2012) · Nature · doi:10.1038/nature10725 · Cited by 1,596
The JAK-STAT Pathway at Twenty
Stark, G. R., & Darnell, J. E. (2012) · Immunity · doi:10.1016/j.immuni.2012.03.013 · Cited by 1,517
Self-citationRobertson, G., Hirst, M., Bainbridge, M., Bilenky, M., Zhao, Y., Zeng, T., Euskirchen, G., Bernier, B., Varhol, R., Delaney, A., et al. (2007) · Nature Methods · doi:10.1038/nmeth1068 · Cited by 1,454
STAT3 Mutations in the Hyper-IgE Syndrome
Holland, S. M., DeLeo, F. R., Elloumi, H. Z., Hsu, A. P., Uzel, G., Brodsky, N., Freeman, A. F., Demidowich, A., Davis, J., Turner, M. L., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073687 · Cited by 1,221
Jak2 Is Essential for Signaling through a Variety of Cytokine Receptors
Parganas, E., Wang, D., Stravopodis, D., Topham, D. J., Marine, J.-C., Teglund, S., Vanin, E. F., Bodner, S., Colamonici, O. R., van Deursen, J. M., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81167-8 · Cited by 1,156
Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome
Minegishi, Y., Saito, M., Tsuchiya, S., Tsuge, I., Takada, H., Hara, T., Kawamura, N., Ariga, T., Pasic, S., Stojkovic, O., et al. (2007) · Nature · doi:10.1038/nature06096 · Cited by 1,048
STAT4 and the Risk of Rheumatoid Arthritis and Systemic Lupus Erythematosus
Remmers, E. F., Plenge, R. M., Lee, A. T., Graham, R. R., Hom, G., Behrens, T. W., de Bakker, P. I. W., Le, J. M., Lee, H.-S., Batliwalla, F., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073003 · Cited by 1,041
Akira, S., Nishio, Y., Inoue, M., Wang, X.-J., We, S., Matsusaka, T., Yoshida, K., Sudo, T., Naruto, M., & Kishimoto, T. (1994) · Cell · doi:10.1016/0092-8674(94)90235-6 · Cited by 1,019
Enhanced DNA-Binding Activity of a Stat3-Related Protein in Cells Transformed by the Src Oncoprotein
Yu, C.-L., Meyer, D. J., Campbell, G. S., Larner, A. C., Carter-Su, C., Schwartz, J., & Jove, R. (1995) · Science · doi:10.1126/science.7541555 · Cited by 931
Jak2 Deficiency Defines an EssentialDevelopmental Checkpoint in DefinitiveHematopoiesis
Neubauer, H., Cumano, A., Müller, M., Wu, H., Huffstadt, U., & Pfeffer, K. (1998) · Cell · doi:10.1016/s0092-8674(00)81168-x · Cited by 914
Defective NK Cell Activity and Th1 Response in IL-18–Deficient Mice
Takeda, K., Tsutsui, H., Yoshimoto, T., Adachi, O., Yoshida, N., Kishimoto, T., Okamura, H., Nakanishi, K., & Akira, S. (1998) · Immunity · doi:10.1016/s1074-7613(00)80543-9 · Cited by 911
Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor
Meydan, N., Grunberger, T., Dadi, H., Shahar, M., Arpaia, E., Lapidot, Z., Leeder, J. S., Freedman, M., Cohen, A., Gazit, A., et al. (1996) · Nature · doi:10.1038/379645a0 · Cited by 897
Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)
Macchi, P., Villa, A., Giliani, S., Sacco, M. G., Frattini, A., Porta, F., Ugazio, A. G., Johnston, J. A., Candotti, F., O'Sheai, J. J., et al. (1995) · Nature · doi:10.1038/377065a0 · Cited by 877
A protein tyrosine kinase in the interferon αβ signaling pathway
Velazquez, L., Fellous, M., Stark, G. R., & Pellegrini, S. (1992) · Cell · doi:10.1016/0092-8674(92)90105-l · Cited by 872
Self-citationLatent Enhancers Activated by Stimulation in Differentiated Cells
Ostuni, R., Piccolo, V., Barozzi, I., Polletti, S., Termanini, A., Bonifacio, S., Curina, A., Prosperini, E., Ghisletti, S., & Natoli, G. (2013) · Cell · doi:10.1016/j.cell.2012.12.018 · Cited by 867
An Interleukin-4-Induced Transcription Factor: IL-4 Stat
Hou, J., Schindler, U., Henzel, W. J., Ho, T. C., Brasseur, M., & McKnight, S. L. (1994) · Science · doi:10.1126/science.8085155 · Cited by 854
Rodig, S. J., Meraz, M. A., White, J. M., Lampe, P. A., Riley, J. K., Arthur, C. D., King, K. L., Sheehan, K. C. F., Yin, L., Pennica, D., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81166-6 · Cited by 853
Wakao, H., Gouilleux, F., & Groner, B. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06495.x · Cited by 826
Levy, D. E., & Lee, C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15650 · Cited by 810
Mutation of Jak3 in a Patient with SCID: Essential Role of Jak3 in Lymphoid Development
Russell, S. M., Tayebi, N., Nakajima, H., Riedy, M. C., Roberts, J. L., Aman, M. J., Migone, T.-S., Noguchi, M., Markert, M. L., Buckley, R. H., et al. (1995) · Science · doi:10.1126/science.270.5237.797 · Cited by 803
Self-citationLiu, L., Okada, S., Kong, X.-F., Kreins, A. Y., Cypowyj, S., Abhyankar, A., Toubiana, J., Itan, Y., Audry, M., Nitschke, P., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110958 · Cited by 797
Zika Virus Targets Human STAT2 to Inhibit Type I Interferon Signaling
Grant, A., Ponia, S. S., Tripathi, S., Balasubramaniam, V., Miorin, L., Sourisseau, M., Schwarz, M. C., Sánchez-Seco, M. P., Evans, M. J., Best, S. M., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.05.009 · Cited by 797
A TEL-JAK2 Fusion Protein with Constitutive Kinase Activity in Human Leukemia
Lacronique, V., Boureux, A., Della Valle, V., Poirel, H., Quang, C. T., Mauchauffé, M., Berthou, C., Lessard, M., Berger, R., Ghysdael, J., et al. (1997) · Science · doi:10.1126/science.278.5341.1309 · Cited by 791
Levy, D. E., & Lee, C.-K. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215650 · Cited by 734
Crystal Structure of a Tyrosine Phosphorylated STAT-1 Dimer Bound to DNA
Chen, X., Vinkemeier, U., Zhao, Y., Jeruzalmi, D., Darnell, J. E., & Kuriyan, J. (1998) · Cell · doi:10.1016/s0092-8674(00)81443-9 · Cited by 720
Self-citationMitochondrial STAT3 Supports Ras-Dependent Oncogenic Transformation
Gough, D. J., Corlett, A., Schlessinger, K., Wegrzyn, J., Larner, A. C., & Levy, D. E. (2009) · Science · doi:10.1126/science.1171721 · Cited by 716
Minegishi, Y., Saito, M., Morio, T., Watanabe, K., Agematsu, K., Tsuchiya, S., Takada, H., Hara, T., Kawamura, N., Ariga, T., et al. (2006) · Immunity · doi:10.1016/j.immuni.2006.09.009 · Cited by 702
JAK2 phosphorylates histone H3Y41 and excludes HP1α from chromatin
Dawson, M. A., Bannister, A. J., Göttgens, B., Foster, S. D., Bartke, T., Green, A. R., & Kouzarides, T. (2009) · Nature · doi:10.1038/nature08448 · Cited by 622
Weichselbaum, R. R., Ishwaran, H., Yoon, T., Nuyten, D. S. A., Baker, S. W., Khodarev, N., Su, A. W., Shaikh, A. Y., Roach, P., Kreike, B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809242105 · Cited by 615
Yang, J., Liao, X., Agarwal, M. K., Barnes, L., Auron, P. E., & Stark, G. R. (2007) · Genes & Development · doi:10.1101/gad.1553707 · Cited by 611
Self-citationPrevention of organ allograft rejection by a specific Janus kinase 3 inhibitor
Changelian, P. S., Flanagan, M. E., Ball, D. J., Kent, C. R., Magnuson, K. S., Martin, W. H., Rizzuti, B. J., Sawyer, P. S., Perry, B. D., Brissette, W. H., et al. (2003) · Science · doi:10.1126/science.1087061 · Cited by 607
Self-citationPhosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2
Johnston, J. A., Kawamura, M., Kirken, R. A., Chen, Y.-Q., Blake, T. B., Shibuya, K., Ortaldo, J. R., McVicar, D. W., & O'Shea, J. J. (1994) · Nature · doi:10.1038/370151a0 · Cited by 595
Self-citationGouilleux, F., Wakao, H., Mundt, M., & Groner, B. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06756.x · Cited by 588
Human intracellular ISG15 prevents interferon-α/β over-amplification and auto-inflammation
Zhang, X., Bogunovic, D., Payelle-Brogard, B., Francois-Newton, V., Speer, S. D., Yuan, C., Volpi, S., Li, Z., Sanal, O., Mansouri, D., et al. (2015) · Nature · doi:10.1038/nature13801 · Cited by 558
Liu, X., Robinson, G. W., Gouilleux, F., Groner, B., & Hennighausen, L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.19.8831 · Cited by 557
Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I
Migone, T.-S., Lin, J.-X., Cereseto, A., Mulloy, J. C., O'Shea, J. J., Franchini, G., & Leonard, W. J. (1995) · Science · doi:10.1126/science.7604283 · Cited by 557
Self-citationEarly-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations
Milner, J. D., Vogel, T. P., Forbes, L., Ma, C. A., Stray-Pedersen, A., Niemela, J. E., Lyons, J. J., Engelhardt, K. R., Zhang, Y., Topcagic, N., et al. (2015) · Blood · doi:10.1182/blood-2014-09-602763 · Cited by 557
Stat1-dependent and -independent pathways in IFN-γ-dependent signaling
Ramana, C. V., Gil, M. P., Schreiber, R. D., & Stark, G. R. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(01)02118-4 · Cited by 555
Self-citationDefects in B Lymphocyte Maturation and T Lymphocyte Activation in Mice Lacking Jak3
Thomis, D. C., Gurniak, C. B., Tivol, E., Sharpe, A. H., & Berg, L. J. (1995) · Science · doi:10.1126/science.270.5237.794 · Cited by 537
Interferon target-gene expression and epigenomic signatures in health and disease
Barrat, F. J., Crow, M. K., & Ivashkiv, L. B. (2019) · Nature Immunology · doi:10.1038/s41590-019-0466-2 · Cited by 530
Wilks, A. F., Harpur, A. G., Kurban, R. R., Ralph, S. J., Zürcher, G., & Ziemiecki, A. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.4.2057 · Cited by 528
SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling
Miorin, L., Kehrer, T., Sanchez-Aparicio, M. T., Zhang, K., Cohen, P., Patel, R. S., Cupic, A., Makio, T., Mei, M., Moreno, E., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2016650117 · Cited by 527
Type I Interferon in Chronic Virus Infection and Cancer
Snell, L. M., McGaha, T. L., & Brooks, D. G. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.05.005 · Cited by 500
Nguyen, K. B., Watford, W. T., Salomon, R., Hofmann, S. R., Pien, G. C., Morinobu, A., Gadina, M., O'Shea, J. J., & Biron, C. A. (2002) · Science · doi:10.1126/science.1074900 · Cited by 494
Self-citationCooperation of Stat2 and p300/CBP in signalling induced by interferon-α
Bhattacharya, S., Eckner, R., Grossman, S., Oldread, E., Arany, Z., D'Andrea, A., & Livingston, D. M. (1996) · Nature · doi:10.1038/383344a0 · Cited by 493
Developmental defects of lymphoid cells in Jak3 kinase-deficient mice
Park, S. Y., Saijo, K., Takahashi, T., Osawa, M., Areas, H., Hirayama, N., Miyake, K., Nakauchi, H., Shirasawa, T., & Saito, T. (1995) · Immunity · doi:10.1016/1074-7613(95)90066-7 · Cited by 487
Harrison, D. A., Binari, R., Nahreini, T. S., Gilman, M., & Perrimon, N. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07285.x · Cited by 469
Dynamic profiling of the protein life cycle in response to pathogens
Jovanovic, M., Rooney, M. S., Mertins, P., Przybylski, D., Chevrier, N., Satija, R., Rodriguez, E. H., Fields, A. P., Schwartz, S., Raychowdhury, R., et al. (2015) · Science · doi:10.1126/science.1259038 · Cited by 460
Greenlund, A. C., Farrar, M. A., Viviano, B. L., & Schreiber, R. D. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06422.x · Cited by 454
NS5 of Dengue Virus Mediates STAT2 Binding and Degradation
Ashour, J., Laurent-Rolle, M., Shi, P.-Y., & García-Sastre, A. (2009) · Journal of Virology · doi:10.1128/jvi.02188-08 · Cited by 451
Hu, G., Tang, Q., Sharma, S., Yu, F., Escobar, T. M., Muljo, S. A., Zhu, J., & Zhao, K. (2013) · Nature Immunology · doi:10.1038/ni.2712 · Cited by 406
Stat3 and Stat4: members of the family of signal transducers and activators of transcription.
Zhong, Z., Wen, Z., & Darnell, J. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4806 · Cited by 397
Self-citationReich, N. C., & Liu, L. (2006) · Nature Reviews Immunology · doi:10.1038/nri1885 · Cited by 376
Super-enhancers delineate disease-associated regulatory nodes in T cells
Vahedi, G., Kanno, Y., Furumoto, Y., Jiang, K., Parker, S. C. J., Erdos, M. R., Davis, S. R., Roychoudhuri, R., Restifo, N. P., Gadina, M., et al. (2015) · Nature · doi:10.1038/nature14154 · Cited by 374
Self-citationSTATs Shape the Active Enhancer Landscape of T Cell Populations
Vahedi, G., Takahashi, H., Nakayamada, S., Sun, H.-W., Sartorelli, V., Kanno, Y., & O’Shea, J. J. (2012) · Cell · doi:10.1016/j.cell.2012.09.044 · Cited by 367
Self-citationZhang, C., Yue, C., Herrmann, A., Song, J., Egelston, C., Wang, T., Zhang, Z., Li, W., Lee, H., Aftabizadeh, M., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2019.10.013 · Cited by 366
Chatterjee-Kishore, M., Wright, K. L., Ting, J. P.-Y., & Stark, G. R. (2000) · The EMBO Journal · doi:10.1093/emboj/19.15.4111 · Cited by 346
Self-citationKanno, Y., Vahedi, G., Hirahara, K., Singleton, K., & O'Shea, J. J. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075058 · Cited by 342
Self-citationRas-Independent Growth Factor Signaling by Transcription Factor Tyrosine Phosphorylation
Silvennoinen, O., Schindler, C., Schlessinger, J., & Levy, D. E. (1993) · Science · doi:10.1126/science.8378775 · Cited by 338
Parsing the interferon transcriptional network and its disease associations
Mostafavi, S., Yoshida, H., Moodley, D., LeBoité, H., Rothamel, K., Raj, T., Ye, C. J., Chevrier, N., Zhang, S.-Y., Feng, T., et al. (2016) · Cell · doi:10.1016/j.cell.2015.12.032 · Cited by 337
IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage
Cheon, H., Holvey-Bates, E. G., Schoggins, J. W., Forster, S., Hertzog, P., Imanaka, N., Rice, C. M., Jackson, M. W., Junk, D. J., & Stark, G. R. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.203 · Cited by 334
Self-citationMajoros, A., Platanitis, E., Kernbauer-Hölzl, E., Rosebrock, F., Müller, M., & Decker, T. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00029 · Cited by 325
(1990) · PubMed · Cited by 322
Luo, H., Hanratty, W. P., & Dearolf, C. R. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07127.x · Cited by 315
Type I interferon-mediated tumor immunity and its role in immunotherapy
Yu, R., Zhu, B., & Chen, D. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04219-z · Cited by 309
JAK2, a third member of the JAK family of protein tyrosine kinases.
Harpur, A. G., Andres, A. ‐., Ziemiecki, A., Aston, R. R., & Wilks, A. F. (1992) · PubMed · Cited by 306
Insights into Cytokine–Receptor Interactions from Cytokine Engineering
Spangler, J. B., Moraga, I., Mendoza, J. L., & Garcia, K. C. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120211 · Cited by 304
Kershaw, N. J., Murphy, J. M., Liau, N. P. D., Varghese, L. N., Laktyushin, A., Whitlock, E. L., Lucet, I. S., Nicola, N. A., & Babon, J. J. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2519 · Cited by 301
Human USP18 deficiency underlies type 1 interferonopathy leading to severe pseudo-TORCH syndrome
Meuwissen, M. E. C., Schot, R., Buta, S., Oudesluijs, G., Tinschert, S., Speer, S. D., Li, Z., van Unen, L., Heijsman, D., Goldmann, T., et al. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151529 · Cited by 294
Burke, J. R., Cheng, L., Gillooly, K. M., Strnad, J., Zupa-Fernandez, A., Catlett, I. M., Zhang, Y., Heimrich, E. M., McIntyre, K. W., Cunningham, M. D., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw1736 · Cited by 289
Mediator Condensates Localize Signaling Factors to Key Cell Identity Genes
Zamudio, A. V., Dall’Agnese, A., Henninger, J. E., Manteiga, J. C., Afeyan, L. K., Hannett, N. M., Coffey, E. L., Li, C. H., Oksuz, O., Sabari, B. R., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.08.016 · Cited by 283
Nusinzon, I., & Horvath, C. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2433987100 · Cited by 282
Self-citationStructure of the Amino-Terminal Protein Interaction Domain of STAT-4
Vinkemeier, U., Moarefi, I., Darnell, J. E., & Kuriyan, J. (1998) · Science · doi:10.1126/science.279.5353.1048 · Cited by 270
Self-citationRegulatory Networks Involving STATs, IRFs, and NFκB in Inflammation
Platanitis, E., & Decker, T. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02542 · Cited by 244
Xu, W., Edwards, M. R., Borek, D. M., Feagins, A. R., Mittal, A., Alinger, J. B., Berry, K. N., Yen, B., Hamilton, J., Brett, T. J., et al. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.07.008 · Cited by 241
Stat Protein Transactivation Domains Recruit p300/CBP through Widely Divergent Sequences
Paulson, M., Pisharody, S., Pan, L., Levy, D. E., Guadagno, S., & Mui, A. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25343 · Cited by 234
A molecular switch from STAT2-IRF9 to ISGF3 underlies interferon-induced gene transcription
Platanitis, E., Demiroz, D., Schneller, A., Fischer, K., Capelle, C., Hartl, M., Gossenreiter, T., Müller, M., Novatchkova, M., & Decker, T. (2019) · Nature Communications · doi:10.1038/s41467-019-10970-y · Cited by 233
Ulane, C. M., & Horvath, C. M. (2002) · Virology · doi:10.1006/viro.2002.1773 · Cited by 225
Self-citationRegulation of cytokine signaling pathways by PIAS proteins
Shuai, K. (2006) · Cell Research · doi:10.1038/sj.cr.7310027 · Cited by 221
Mu, J., Fang, Y., Yang, Q., Shu, T., Wang, A., Huang, M., Jin, L., Deng, F., Qiu, Y., & Zhou, X. (2020) · Cell Discovery · doi:10.1038/s41421-020-00208-3 · Cited by 213
Chang, H.-M., Paulson, M., Holko, M., Rice, C. M., Williams, B. R. G., Marié, I., & Levy, D. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400567101 · Cited by 212
Opposing macrophage polarization programs show extensive epigenomic and transcriptional cross-talk
Piccolo, V., Curina, A., Genua, M., Ghisletti, S., Simonatto, M., Sabò, A., Amati, B., Ostuni, R., & Natoli, G. (2017) · Nature Immunology · doi:10.1038/ni.3710 · Cited by 211
ISG15 deficiency and increased viral resistance in humans but not mice
Speer, S. D., Li, Z., Buta, S., Payelle-Brogard, B., Qian, L., Vigant, F., Rubino, E., Gardner, T. J., Wedeking, T., Hermann, M., et al. (2016) · Nature Communications · doi:10.1038/ncomms11496 · Cited by 206
Hasni, S. A., Gupta, S., Davis, M., Poncio, E., Temesgen-Oyelakin, Y., Carlucci, P. M., Wang, X., Naqi, M., Playford, M. P., Goel, R. R., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23361-z · Cited by 201
Self-citationLin, J.-X., Li, P., Liu, D., Jin, H. T., He, J., Rasheed, M. A. U., Rochman, Y., Wang, L., Cui, K., Liu, C., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.02.017 · Cited by 200
How cancer cells make and respond to interferon-I
Cheon, H., Wang, Y., Wightman, S. M., Jackson, M. W., & Stark, G. R. (2023) · Trends in Cancer · doi:10.1016/j.trecan.2022.09.003 · Cited by 192
Self-citationMandal, M., Powers, S. E., Maienschein-Cline, M., Bartom, E. T., Hamel, K. M., Kee, B. L., Dinner, A. R., & Clark, M. R. (2011) · Nature Immunology · doi:10.1038/ni.2136 · Cited by 190
Carbognin, E., Betto, R. M., Soriano, M. E., Smith, A. G., & Martello, G. (2016) · The EMBO Journal · doi:10.15252/embj.201592629 · Cited by 188
Hirahara, K., Onodera, A., Villarino, A. V., Bonelli, M. M., Sciumè, G., Laurence, A. D. J., Sun, H., Brooks, S. R., Vahedi, G., Shih, H., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.04.014 · Cited by 184
Self-citationPatel, M. C., Debrosse, M., Smith, M., Dey, A., Huynh, W., Sarai, N., Heightman, T. D., Tamura, T., & Ozato, K. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01180-12 · Cited by 183
Levy, D., Larner, A., Chaudhuri, A., Babiss, L. E., & Darnell, J. E. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.23.8929 · Cited by 181
Self-citationStructure of a Janus kinase cytokine receptor complex reveals the basis for dimeric activation
Glassman, C. R., Tsutsumi, N., Saxton, R. A., Lupardus, P. J., Jude, K. M., & Garcia, K. C. (2022) · Science · doi:10.1126/science.abn8933 · Cited by 181
Aberrant type 1 immunity drives susceptibility to mucosal fungal infections.
Break, T. J., Oikonomou, V., Dutzan, N., Desai, J. V., Swidergall, M., Freiwald, T., Chauss, D., Harrison, O. J., Alejo, J., Williams, D. W., et al. (2021) · Science · doi:10.1126/science.aay5731 · Cited by 175
Bel, K. L. D., Ragotte, R. J., Saferali, A., Lee, S., Vercauteren, S., Mostafavi, S., Schreiber, R. A., Prendiville, J., Phang, M. S., Halparin, J., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.12.957 · Cited by 172
Tyrosine phosphorylation regulates the partitioning of STAT1 between different dimer conformations
Wenta, N., Strauss, H., Meyer, S., & Vinkemeier, U. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802130105 · Cited by 171
Zhong, M., Henriksen, M. A., Takeuchi, K., Schaefer, O., Liu, B., Hoeve, J. T., Ren, Z., Mao, X., Chen, X., Shuai, K., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501063102 · Cited by 169
Self-citationFarlik, M., Reutterer, B., Schindler, C., Greten, F. R., Vogl, C., Müller, M. M., & Decker, T. (2010) · Immunity · doi:10.1016/j.immuni.2010.07.001 · Cited by 160
Porcine Deltacoronavirus nsp5 Antagonizes Type I Interferon Signaling by Cleaving STAT2
Zhu, X., Wang, D., Zhou, J., Pan, T., Chen, J., Yang, Y., Lv, M., Ye, X., Peng, G., Fang, L., et al. (2017) · Journal of Virology · doi:10.1128/jvi.00003-17 · Cited by 159
Early-onset autoimmunity associated with SOCS1 haploinsufficiency
Hadjadj, J., Castro, C. N., Tusseau, M., Stolzenberg, M.-C., Mazerolles, F., Aladjidi, N., Armstrong, M., Ashrafian, H., Cutcutache, I., Ebetsberger-Dachs, G., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18925-4 · Cited by 156
STAT1 acts as a tumor promoter for leukemia development
Kovačic, B., Stoiber, D., Moriggl, R., Weisz, E., Ott, R. G., Kreibich, R., Levy, D. E., Beug, H., Freissmuth, M., & Sexl, V. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.05.025 · Cited by 155
Opposing roles of STAT1 and STAT3 in IL-21 function in CD4 + T cells
Wan, E. C. K., Andraski, A. B., Spolski, R. J., Li, P., Kazemian, M., Oh, J., Samsel, L., Swanson, P. A., McGavern, D. B., Sampaio, E. P., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1511711112 · Cited by 148
Avalle, L., Camporeale, A., Morciano, G., Caroccia, N., Ghetti, E., Orecchia, V., Viavattene, D., Giorgi, C., Pinton, P., & Poli, V. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0171-y · Cited by 142
Gollob, J., Schnipper, C. P., Murphy, E. A., Ritz, J., & Frank, D. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.8.4472 · Cited by 140
Gruber, C. N., Calis, J. J. A., Buta, S., Evrony, G. D., Martin, J. C., Uhl, S. A., Caron, R., Jarchin, L., Dunkin, D., Phelps, R. G., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.07.006 · Cited by 140
Martinez-Moczygemba, M., Gutch, M. J., French, D. L., & Reich, N. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.32.20070 · Cited by 132
Biallelic JAK1 mutations in immunodeficient patient with mycobacterial infection
Eletto, D., Burns, S. O., Angulo, I., Plagnol, V., Gilmour, K. C., Henriquez, F., Curtis, J. W., Gaspar, M. A., Nowak, K., Daza-Cajigal, V., et al. (2016) · Nature Communications · doi:10.1038/ncomms13992 · Cited by 129
Functional Importance of Stat3 Tetramerization in Activation of the α2-Macroglobulin Gene
Zhang, X., & Darnell, J. E., Jr. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104978200 · Cited by 124
ATP binding to the pseudokinase domain of JAK2 is critical for pathogenic activation
Hammarén, H. M., Ungureanu, D., Grisouard, J., Skoda, R. C., Hubbard, S. R., & Silvennoinen, O. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1423201112 · Cited by 122
STAT heterodimers in immunity: A mixed message or a unique signal?
Delgoffe, G. M., & Vignali, D. A. A. (2013) · JAK-STAT · doi:10.4161/jkst.23060 · Cited by 120
IFN-Stimulated transcription through a TBP-free acetyltransferase complex escapes viral shutoff
Paulson, M. S., Press, C., Smith, E., Tanese, N., & Levy, D. E. (2002) · Nature Cell Biology · doi:10.1038/ncb747 · Cited by 120
IRF9 and unphosphorylated STAT2 cooperate with NF-κB to drive IL6 expression
Jing, N., Wang, Y., Yang, J. B., & Stark, G. R. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1714102115 · Cited by 116
Self-citationJAK Inhibitor Therapy in a Child with Inherited USP18 Deficiency
Alsohime, F., Martín-Fernández, M., Temsah, M.-H. A., Alabdulhafid, M., Voyer, T. L., Alghamdi, M. A., Qiu, X., Alotaibi, N., Alkahtani, A. R., Buta, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1905633 · Cited by 106
Saevarsdóttir, S., Stefánsdóttir, L., Sulem, P., Þorleifsson, G., Ferkingstad, E., Rutsdottir, G., Glintborg, B., Westerlind, H., Gröndal, G., Loft, I. C., et al. (2022) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2021-221754 · Cited by 106
STAT1-cooperative DNA binding distinguishes type 1 from type 2 interferon signaling
Begitt, A., Droescher, M., Meyer, T., Schmid, C. D., Baker, M., Antunes, F., Knobeloch, K., Owen, M. R., Naumann, R., Decker, T., et al. (2014) · Nature Immunology · doi:10.1038/ni.2794 · Cited by 104
Systemic Type I IFN Inflammation in Human ISG15 Deficiency Leads to Necrotizing Skin Lesions
Martín-Fernández, M., García‐Morato, M. B., Gruber, C. N., Loza, S. M. M., Malik, M. N. H., Alsohime, F., Alakeel, A., Valdéz, R., Buta, S., Buda, G., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107633 · Cited by 101
The Chromatin-Remodeling BAF Complex Mediates Cellular Antiviral Activities by Promoter Priming
Cui, K., Tailor, P. B., Liu, H., Chen, X., Ozato, K., & Zhao, K. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.10.4476-4486.2004 · Cited by 97
Acetylation modulates the STAT signaling code
Wieczorek, M., Ginter, T., Brand, P., Heinzel, T., & Krämer, O. H. (2012) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2012.06.005 · Cited by 97
Unphosphorylated STAT5A stabilizes heterochromatin and suppresses tumor growth
Hu, X., Dutta, P., Tsurumi, A., Li, J., Wang, J., Land, H., & Li, W. X. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221243110 · Cited by 95
Antagonism of B cell enhancer networks by STAT5 drives leukemia and poor patient survival
Katerndahl, C. D. S., Heltemes-Harris, L. M., Willette, M., Henzler, C. M., Frietze, S. E., Yang, R., Schjerven, H., Silverstein, K. A. T., Ramsey, L. B., Hubbard, G. K., et al. (2017) · Nature Immunology · doi:10.1038/ni.3716 · Cited by 95
Structural basis of STAT2 recognition by IRF9 reveals molecular insights into ISGF3 function
Rengachari, S., Groiss, S., Devos, J. M., Caron, E., Grandvaux, N., & Panne, D. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718426115 · Cited by 91
A reinterpretation of the dimerization interface of the N‐terminal Domains of STATs
Chen, X., Bhandari, R., Vinkemeier, U., van den Akker, F., Darnell, J. E., Jr., & Kuriyan, J. (2003) · Protein Science · doi:10.1110/ps.0218903 · Cited by 89
Ross, S. H., Rollings, C., Anderson, K. E., Hawkins, P. T., Stephens, L. R., & Cantrell, D. A. (2016) · Immunity · doi:10.1016/j.immuni.2016.07.022 · Cited by 89
Facile discovery of surrogate cytokine agonists
Yen, M., Ren, J., Liu, Q., Glassman, C. R., Sheahan, T. P., Picton, L. K., Moreira, F. R., Rustagi, A., Jude, K. M., Zhao, X., et al. (2022) · Cell · doi:10.1016/j.cell.2022.02.025 · Cited by 89
Transcriptional and chromatin regulation in interferon and innate antiviral gene expression
Au-Yeung, N., & Horvath, C. M. (2018) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2018.10.003 · Cited by 88
Self-citationIdentification and chromosomal mapping of new human tyrosine kinase genes.
Krolewski, J. J., Lee, R., Eddy, R. L., Shows, T. B., & Dalla‐Favera, R. (1990) · PubMed · Cited by 87
Selective inhibitors of JAK1 targeting an isoform-restricted allosteric cysteine
Kavanagh, M. E., Horning, B. D., Khattri, R., Roy, N., Lu, J. P., Whitby, L. R., Ye, E., Brannon, J. C., Parker, A., Chick, J. M., et al. (2022) · Nature Chemical Biology · doi:10.1038/s41589-022-01098-0 · Cited by 86
Linossi, E., & Nicholson, S. (2015) · Immunological Reviews · doi:10.1111/imr.12305 · Cited by 85
Ahmed, C. M. I., Larkin, J., & Johnson, H. M. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00183 · Cited by 84
A partial form of inherited human USP18 deficiency underlies infection and inflammation
Martín-Fernández, M., Buta, S., Voyer, T. L., Li, Z., Dynesen, L. T., Vuillier, F., Franklin, L., Ailal, F., Amancio, A. M. T. D. S., Malle, L., et al. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20211273 · Cited by 83
A three-dimensional model of Suppressor Of Cytokine Signalling 1 (SOCS-1).
Giordanetto, F., & Kroemer, R. T. (2003) · Protein Engineering · doi:10.1093/proeng/gzg015 · Cited by 81
Göertz, G. P., McNally, K. L., Robertson, S. J., Best, S. M., Pijlman, G. P., & Fros, J. J. (2018) · Journal of Virology · doi:10.1128/jvi.01008-18 · Cited by 80
Wang, C., Sun, M., Yuan, X., Ji, L., Jin, Y., Cardona, C. J., & Xing, Z. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.745729 · Cited by 77
Cheon, H., Holvey-Bates, E. G., McGrail, D. J., & Stark, G. R. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2112258118 · Cited by 77
Self-citationDeconvoluting global cytokine signaling networks in natural killer cells
Wiedemann, G. M., Santosa, E. K., Grassmann, S. A., Sheppard, S., Luduec, J.-B. L., Adams, N. M., Dang, C., Hsu, K. C., Sun, J. C.-Y., & Lau, C. M. (2021) · Nature Immunology · doi:10.1038/s41590-021-00909-1 · Cited by 75
TYK2 inhibition reduces type 3 immunity and modifies disease progression in murine spondyloarthritis
Gracey, E., Hromadová, D., Lim, M., Qaiyum, Z., Zeng, M., Yao, Y., Srinath, A., Baglaenko, Y., Yeremenko, N., Westlin, W., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci126567 · Cited by 74
Ho, J., Pelzel, C., Begitt, A., Mee, M., Elsheikha, H. M., Scott, D. J., & Vinkemeier, U. (2016) · PLoS Biology · doi:10.1371/journal.pbio.2000117 · Cited by 68
Signalling input from divergent pathways subverts B cell transformation
Chan, L. N., Murakami, M. A., Robinson, M. E., Caeser, R., Sadras, T., Lee, J. W., Cosgun, K. N., Kume, K., Khairnar, V., Xiao, G., et al. (2020) · Nature · doi:10.1038/s41586-020-2513-4 · Cited by 67
Role of Metazoan Mediator Proteins in Interferon-Responsive Transcription
Lau, J. F., Nusinzon, I., Burakov, D., Freedman, L. P., & Horvath, C. M. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.23.2.620-628.2003 · Cited by 66
Self-citationMarié, I. J., Chang, H.-M., & Levy, D. E. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20180520 · Cited by 66
Aberrant inflammatory responses to type I interferon in STAT2 or IRF9 deficiency
Gothe, F., Spegarova, J. S., Hatton, C. F., Griffin, H. R., Sargent, T., Cowley, S. A., James, W., Roppelt, A., Shcherbina, A. Y., Hauck, F. H., et al. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.01.026 · Cited by 64
Cui, X., Zhang, L., Luo, J., Rajasekaran, A., Hazra, S., Cacalano, N. A., & Dubinett, S. M. (2007) · Oncogene · doi:10.1038/sj.onc.1210222 · Cited by 63
Peron, M., Meneghetti, G., Meneghetti, G., Martorano, L., Betto, R. M., Facchinello, N., Tesoriere, A., Tiso, N., Martello, G., & Argenton, F. (2021) · Development · doi:10.1242/dev.199477 · Cited by 59
Garama, D. J., Harris, T. J., White, C. L., Rossello, F. J., Abdul‐Hay, M., Gough, D. J., & Levy, D. E. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00541-15 · Cited by 58
A virus-induced conformational switch of STAT1-STAT2 dimers boosts antiviral defenses
Wang, Y., Song, Q., Huang, W., Lin, Y., Wang, X., Wang, C., Willard, B. B., Zhao, C., Jing, N., Holvey-Bates, E. G., et al. (2020) · Cell Research · doi:10.1038/s41422-020-0386-6 · Cited by 55
Self-citationStructural and functional consequences of the STAT5BN642H driver mutation
de Araujo, E. D., Erdogan, F., Neubauer, H., Meneksedag-Erol, D., Manaswiyoungkul, P., Eram, M., Seo, H., Qadree, A. K., Israelian, J., Orlova, A., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10422-7 · Cited by 54
Sciumé, G., Mikami, Y., Jankovic, D., Nagashima, H., Villarino, A. V., Morrison, T. A., Yao, C., Signorella, S., Sun, H.-W., Brooks, S., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.09.008 · Cited by 53
Self-citationInterferons reshape the 3D conformation and accessibility of macrophage chromatin
Platanitis, E., Gruener, S., Geetha, A. R. S. J., Boccuni, L., Vogt, A., Novatchkova, M., Sommer, A., Barozzi, I., Müller, M. M., & Decker, T. (2022) · iScience · doi:10.1016/j.isci.2022.103840 · Cited by 49
Mimetics of suppressor of cytokine signaling 3: Novel potential therapeutics in triple breast cancer
Manna, S. L., Lee, E.-M., Ouzounova, M., Natale, C. D., Novellino, E., Merlino, A., Körkaya, H., & Marasco, D. (2018) · International Journal of Cancer · doi:10.1002/ijc.31594 · Cited by 47
A STAT5B–CD9 axis determines self-renewal in hematopoietic and leukemic stem cells
Kollmann, S., Grausenburger, R., Klampfl, T., Prchal‐Murphy, M., Bastl, K., Pisa, H., Knab, V. M., Brandstoetter, T., Doma, E., Sperr, W. R., et al. (2021) · Blood · doi:10.1182/blood.2021010980 · Cited by 47
Li, J., Williams, M., Park, H. J., Bastos, H. P., Wang, X., Prins, D., Wilson, N. K., Johnson, C., Sham, K., Wantoch, M., et al. (2022) · Blood · doi:10.1182/blood.2021014009 · Cited by 40
Negative regulation of type I IFN signaling by phosphorylation of STAT2 on T387
Wang, Y., Jing, N., Willard, B. B., Wang, X., Yang, J. B., & Stark, G. R. (2016) · The EMBO Journal · doi:10.15252/embj.201694834 · Cited by 37
Self-citationInterleukin-2 superkines by computational design
Ren, J., Chu, A. E., Jude, K. M., Picton, L. K., Kare, A. J., Su, L., Romero, A. M., Huang, P., & García, K. C. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2117401119 · Cited by 36
The Human RVB Complex Is Required for Efficient Transcription of Type I Interferon-Stimulated Genes
Gnatovskiy, L., Mita, P., & Levy, D. E. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01562-12 · Cited by 33
Integrating non-coding RNAs in JAK-STAT regulatory networks
Witte, S. J., & Muljo, S. A. (2014) · JAK-STAT · doi:10.4161/jkst.28055 · Cited by 31
Analysis of Gene Expression Using High-Density and IFN-γ-Specific Low-Density cDNA Arrays
Aberger, F., Costa‐Pereira, A. P., Schlaak, J., Williams, T. M., O’Shaughnessy, R. F. L., Hollaus, G., Kerr, I. M., & Frischauf, A. (2001) · Genomics · doi:10.1006/geno.2001.6623 · Cited by 24
Mechanisms encoding STAT functional diversity for context-specific inflammatory responses
Myers, S. A., & Gottschalk, R. A. (2022) · Current Opinion in Immunology · doi:10.1016/j.coi.2022.01.001 · Cited by 20
Oncogenic dependency on STAT3 serine phosphorylation in KRAS mutant lung cancer
Alhayyani, S., McLeod, L., West, A. C., Balic, J. J., Hodges, C., Yu, L., Smith, J. A., Prodanovic, Z., Bozinovski, S., Kumar, B., et al. (2021) · Oncogene · doi:10.1038/s41388-021-02134-4 · Cited by 13
Cited by
TGF-β signaling in health, disease and therapeutics
Deng, Z., Fan, T., Xiao, C., Tian, H., Zheng, Y., Li, C., & He, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01764-w · Cited by 1,168
Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer
Xue, C., Yao, Q., Gu, X., Shi, Q., Yuan, X., Chu, Q., Bao, Z., Lu, J., & Li, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01468-7 · Cited by 699
Therapeutic strategies for COVID-19: progress and lessons learned
Li, G., Hilgenfeld, R., Whitley, R., & De Clercq, E. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00672-y · Cited by 676
Hepatocellular carcinoma: signaling pathways and therapeutic advances
Zheng, J., Wang, S., Xia, L., Sun, Z., Chan, K. M., Bernards, R., Qin, W., Chen, J., Xia, Q., & Jin, H. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02075-w · Cited by 341
Liver diseases: epidemiology, causes, trends and predictions
Gan, C., Yuan, Y., Shen, H., Gao, J., Kong, X., Che, Z., Guo, Y., Wang, H., Dong, E., & Xiao, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02072-z · Cited by 310
Metadata
- Authors
- Philips, R. L., Wang, Y., Cheon, H., Kanno, Y., Gadina, M., Sartorelli, V., Horvath, C. M., Darnell, J. E., Stark, G. R., & O’Shea, J. J.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2022-10
- Volume
- 185
- Issue
- 21
- Pages
- 3857-3876
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W4305014652
- Cited by
- 720
- References
- 166
- FWCI
- 47.67
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.